Touch on One Thumb, RSI on the Other Thumb: Which Surgery Shows Better Results

April 16, 2024 updated by: Schulthess Klinik

Touch on One Thumb, RSI on the Other Thumb: Which Surgery Shows Better Results: An Ambidirectional Trial

The study aims to determine whether CMC I arthroplasty using a Touch® implant results in higher patient satisfaction compared to RSI arthroplasty in the medium-term in patients with primary thumb osteoarthritis. Additionally, the study compares the patients' clinical and self-reported outcomes between the Touch® implant and the RSI arthroplasty. Therefore, patients with a Touch® implant in one thumb and an RSI arthroplasty in the other thumb will be recruited.

Study Overview

Detailed Description

Patients suffering from osteoarthritis in the first carpometacarpal joint (CMC I OA) are often surgically treated with a resection-suspension-interposition (RSI) arthroplasty. An alternative technique is an arthroplasty with a Touch® implant. There is a growing body of evidence indicating that patients with a Touch® prosthesis recover significantly faster and return to work more quickly than patients after an RSI arthroplasty. However, there have been no studies comparing the two operations in the same patient. By recruiting patients with a Touch® implant in one thumb and an RSI arthroplasty in the other thumb, this study aims to investigate whether CMC I arthroplasty using a Touch® implant leads to higher patient satisfaction compared to RSI arthroplasty in the medium-term. Further patient-reported and clinical outcomes will be assessed to compare the two surgeries.

Study Type

Observational

Enrollment (Actual)

14

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Zurich, Switzerland, 8008
        • Schulthess Klinik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The study population consists of patients with CMC I joint osteoarthritis. They have a Touch® prosthesis in one thumb and an RSI arthroplasty in the other.

Description

Inclusion Criteria:

  • Informed Consent signed by the patient.
  • Patient is diagnosed with primary OA in both CMC I joints and was operated with a Touch® prosthesis on one thumb and with an RSI arthroplasty on the other thumb.

Exclusion Criteria:

  • Patient with any type of revision surgery at the CMC I joint
  • Patient underwent hand surgery within the last three months
  • Legal incompetence

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Touch-RSI

The group consists of patients with a Touch® implant in one thumb and an RSI arthroplasty in the other thumb.

Intervention: Patient questionnaire and clinical examination to investigate differences between the thumb with a Touch® implant and the thumb with an RSI.

The Touch® prosthesis is a medical device approved in Switzerland, which is an effective surgical treatment for advanced CMC I osteoarthritis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction wiht treatment result using 5-point Likert scale
Time Frame: Follow-up at least 3 months to 12 years after surgery
5-point Likert scale ranging from 1 (very dissatisfied) to 5 (very satisfied)
Follow-up at least 3 months to 12 years after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sociodemographic information
Time Frame: Follow-up at least 3 months to 12 years after surgery
Questionnaire
Follow-up at least 3 months to 12 years after surgery
Additional aspects of patient satisfaction with treatment
Time Frame: Follow-up at least 3 months to 12 years after surgery
Questionnaire
Follow-up at least 3 months to 12 years after surgery
Differences between both thumbs
Time Frame: Follow-up at least 3 months to 12 years after surgery
Questionnaire
Follow-up at least 3 months to 12 years after surgery
Brief Michigan Hand Outcomes Questionnaire (MHQ)
Time Frame: Follow-up at least 3 months to 12 years after surgery
The german version of the brief MHQ will be used to assess patient-reported hand function. The score ranges from 0 to 100 with higher scores indicating better hand function.
Follow-up at least 3 months to 12 years after surgery
Grip strength assessed with Jamar Dynamometer
Time Frame: Follow-up at least 3 months to 12 years after surgery
Jamar Dynamometer
Follow-up at least 3 months to 12 years after surgery
Key pinch strength assessed with pinch gauge
Time Frame: Follow-up at least 3 months to 12 years after surgery
Pinch gauge
Follow-up at least 3 months to 12 years after surgery
Range of motion of the humb metacarpal (MCP) and interphalangeal (IP) joint assessed with a goniometer
Time Frame: Follow-up at least 3 months to 12 years after surgery
Used to measure flexion and extension of the thumb metacarpal (MCP) and interphalangeal (IP) joint. The evaluation of active thumb opposition is based on the Kapandji index, ranging from 1 (can touch only the lateral side of the index finger) to 10 (can reach the volar crease of the hand).
Follow-up at least 3 months to 12 years after surgery
Pain at rest and during activities of daily living (ADL) assessed using Numeric rating scales (NRS)
Time Frame: Follow-up at least 3 months to 12 years after surgery
NRS ranging from 0 (no pain) to 10 (worst pain)
Follow-up at least 3 months to 12 years after surgery
Radiographs of both thumbs
Time Frame: Follow-up at least 3 months to 12 years after surgery
To monitor the implant and to assess the scaphometacarpal distance, which can be used to identify migration of the thumb metacarpal bone, a phenomenon often observed after trapeziectomy.
Follow-up at least 3 months to 12 years after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daniel B. Herren, Dr. med., Schulthess Klinik

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 21, 2023

Primary Completion (Actual)

February 10, 2024

Study Completion (Actual)

February 10, 2024

Study Registration Dates

First Submitted

March 30, 2023

First Submitted That Met QC Criteria

April 27, 2023

First Posted (Actual)

May 9, 2023

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Joint Diseases

Clinical Trials on Touch® Prosthesis

3
Subscribe